Navigation Links


IOLs at Biology News

IOLs at Biology Products
IOLs at Biology Technology

Modification of Bio-Rad DC Protein Assay for Use With Thiols

The following protocol is an adaptation for protein determinationin the presence of reducing agents such as DTT (dithiothreitol)and BME (2-mercaptoethanol). This adaptation willeffectively neutralize up to 50 mM BME or 5 mM DTT. DC Protein Assay, Bio-Rad Laboratories catalog numbers 500-0116,...
IOLs at Medicine News
IOLs at Medicine Products

Anterior Chamber PMMA IOLs

Description:The Bausch & Lomb PMMA Anterior Chamber Intraocular Lenses are intended for the visual correction of aphakia in patients 60 years of age or older where a cataractous lens has been removed by primary intracapsular cataract extraction; or primary extracapsular cataract extraction where there is a structural reason that the anterior chamber lens would be the preferred one; or other primary extracaps...
Company:Bausch & Lomb Storz

3 Piece PMMA IOLs

Description:Posterior Chamber Lenses: The Bausch & Lomb PMMA Posterior Chamber Intraocular Lenses are intended to be used for primary implantation for the visual correction of aphakia in patients 60 years of age or older where a cataractous lens has been removed by extracapsular extraction methods. These lenses are intended to be placed in the ciliary sulcus or capsular bag. Lenses with an overall diameter o...
Company:Bausch & Lomb Storz

1 Piece PMMA IOLs

Description:Posterior Chamber Lenses: The Bausch & Lomb PMMA Posterior Chamber Intraocular Lenses are intended to be used for primary implantation for the visual correction of aphakia in patients 60 years of age or older where a cataractous lens has been removed by extracapsular extraction methods. These lenses are intended to be placed in the ciliary sulcus or capsular bag. Lenses with an overall diameter o...
Company:Bausch & Lomb Storz

NuVita Baikoff MA20 Phakic IOLs

Description:Evolutionary refractive lens technology for the phakic eye, clinically validated for safety and efficacy, demonstrates quality of vision and visual acuity comparable to contact lens correction. The lens is compatible with current cataract surgical techniques, and is now available for the correction of myopia in whole and half diopters from -7.00 to -20.00....
Company:Bausch & Lomb Storz
IOLs at Medicine Technology
Other TagsAssetAssetAsset
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
(Date:10/6/2008)...ent kinds of cells have in common with a mixture o...mixtures to separate into two distinct regions. ,...l computer model of the cell sorting process produ...s at Vanderbilt University, and his colleagues at ...ibed in the Oct. 3 issue of the journal Physical ...
(Date:10/6/2008)...ne contained in laboratory yeast has helped an int...s about the process by which protein molecules bin...te gene expression, according to findings reported...o be inert carriers of the genetic instructions fr...al a novel mechanism for creating access to DNA re...
(Date:10/6/2008)...r the Who,s Who of bats, bears, beaked whales and ...task ably assisted by a Field Museum scientific te...ve and diverse mammal collections. , A team head...on of Nature) is releasing its comprehensive statu... diversity, threat and knowledge of the creatures....
(Date:10/6/2008)...food though little research has been done on it, n...od. , In the first research involving people, th...o be absorbed in the human body when consumed both...as AgriLife Research scientists, was published in ... Food Chemistry ., Showing the berry,s absorption...
Breaking Biology News(10 mins):Surface tension drives segregation within cell mixtures 2Early-stage gene transcription creates access to DNA 2Field Museum provides gold standard for mammal survey 2Field Museum provides gold standard for mammal survey 3Research shows Brazilian acai berry antioxidants absorbed by human body 2Research shows Brazilian acai berry antioxidants absorbed by human body 3Two Year Outcomes From Large Head to Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher 28R 29 Sirolimus Eluting Coro 176 1Two Year Outcomes From Large Head to Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher 28R 29 Sirolimus Eluting Coro 176 2Two Year Outcomes From Large Head to Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher 28R 29 Sirolimus Eluting Coro 176 3Two Year Outcomes From Large Head to Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher 28R 29 Sirolimus Eluting Coro 176 4ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 318 1ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 318 2ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 318 3ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 318 4Practice based intervention has sustained benefits for children and families 408 1Practice based intervention has sustained benefits for children and families 408 2Renal function and heart disease and more 404 1Renal function and heart disease and more 404 2
Other Contentsedemaedemaedemaedemaedemaembolusemboluspuncturepuncturepuncturepuncturepuspuspyloruspyelonephritispurpura